PETER THIEL SCHEDULE 13G

Company

Chemomab Therapeutics Ltd.

Filed

March 26, 2021

Accession Number

0001068238-21-000088

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →